SIO2023 Annual Scientific Meeting

Thursday 19 January 2023

Time (EST)

Session Title

IO Essentials: Opening Session

Moderators: Isabel Newton, MD, USCSD; Vijay Ramalingam, MD, BIDMC

• Palliative Care & Compassionate Communication, Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego
• Ethics & Consent, Helena D. Rockwell, BSc, University of California San Diego
• Y90 Basics, Zach Berman, MD, University of California San Diego

Getting Started in IO *

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

• History of IO & SIO, William Rilling, MD, FSIR, Medical College of Wisconsin
• Types of Ablation Technology & How to Select, David Woodrum, MD, PhD, Mayo Clinic
• Chemoembolization: Technique and Evidence, Sarah White, MD, MS, Medical College of Wisconsin
• IO Research, Lynn Savic, MD, Universitatsmedizin Charite Berlin

Professional Development in Practice Setting *

Moderators: Alda Tam, MD, MD Anderson Cancer Center; Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego

• Academic Achievement, Alda Tam, MD, MD Anderson Cancer Center
• Mentorship, Julius Chapiro, MD, PhD, Yale University School of Medicine
• Collaborating with Industry, Riad Salem, MD, MBA, Northwestern University

Preparing for Tumor Boards *

Moderators: William Rilling, MD, FSIR, Medical College of Wisconsin; Riad Salem, MD, MBA, Northwestern University

• Practice Building, William Rilling, MD, FSIR, Medical College of Wisconsin
• IO Cliffnotes: Liver, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
• IO Cliffnotes: Other, Rob Suh, MD, Ronald Reagan UCLA Medical Center
• NCCN Guidelines, Sarah White, MD, MS, Medical College of Wisconsin
• Collaborating with Other Specialties, Ron Arellano, MD, Massachusetts General Hospital

Tumor Board *

Moderators: Riad Salem, MD, MBA, Northwestern University; Sarah White, MD, MS, Medical College of Wisconsin

Panelists: Ron Arellano, MD, Massachusetts General Hospital; Marina Baretti, MD, Johns Hopkins University; Jennifer Berumen. MD, University of California San Diego

Friday 20 January 2023

Time (EST)

Session Title

Breakfast & Industry Symposium Presented by Stryker - Bone Tumor Ablation with Stryker's OptaBlate System *

• Reade De Leacy, MD, Mount Sinai

President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture*

• President's Welcome, Matthew Callstrom, MD, PhD, Mayo Clinic
• Meeting Intro & Thanks, Damian Dupuy, MD, FACR, Cape Cod Hospital
• Laudation, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
• Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Prof. S. Nahum Goldberg, MD, Hadassah Hebrew University Medical Center

Patient-Centered IO Care *

Moderator: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

• Whole Patient Approach to IO, Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Extending Life & Living with Chronic Cancer, Angela Laffan, NP, MSN, University of California San Francisco
• Death & Dying: Realistic Expectations, Cristal Brown, MD, MHS, University of Texas at Austin Dell Medical School
• Caring for Those Who Care: Families & Physicians, Janice Newsome, MD, Emory University
• Survivorship: Patient Perspective, Lynn Lazzaro, Valley Advisors

Expo Hall Break - Discovery Theater Presentation by Guerbet +

HCC Managment in 2023: Moving Towards a More Targeted Treatment Delivery, Pav Najran, MD

Immuno-oncology +

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center

• Basics of Immunology, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
• Immunoadjuvants for Ablation, Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Tumor DNA Research, Mark Yarchoan, MD, Johns Hopkins Univesity
• Immunotherapy Pipeline, Gordon Cohen, MD, AstraZeneca

Lunch & Industry Symposium Presented by Boston Scientific - State-of-the-Art Locoregional Therapies for Liver and Lung *

• Robert Suh, MD, Ronald Reagan UCLA Medical Center
• Beau Toskich, MD, Mayo Clinic

Lunch & Industry Symposium Presented by Guerbet - Optimize Your Treatment Delivery in HCC *

• Introduction, Mike Devane, MD, Greenville Memorial Hospital
• How I Improve Selective Treatment in TARE?, Pav Najran, MD
• How I Deliver with More Precision in DEB-TACE?, Mike Devane, MD, Greenville Memorial Hospital

Expo Hall Afternoon Hours - Discovery Theater Presentation by Genentech +

Advancement in the 1L Treatment of Unresectable or Metastatic HCC, Ripal Gandhi, MD

State of the Art SIO Trials +

Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

• EMERALD1, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
• Imaging Tumor Microenvironments SIO Grant Update, Julius Chapiro, MD, PhD, Yale University School of Medicine
• Immunology SIO Grant Update, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
• Lipiodol SIO Grant Update, Rony Avritscher, MD, MD Anderson Cancer Center
• ACCLAIM, Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center

Expo Hall Networking & Oral Poster Presentations +

• Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Evaluation of Morphological factors affecting the outcome, Ornella Moschovaki-Zeiger, MD, "Attikon" University General Hospital of Athens/Greece
• Safety and efficacy of histotripsy delivery through overlying gas-filled bowel in an ex vivo swine model, Meredith Kisting, MA, University of Wisconsin
• The Diagnostic Value of Transcatheter CTHA for Intraprocedural Detection of previously unknown CRLM during Percutaneous Ablation and Impact on Treatment plan, Susan van der Lei, MD, PhD, Amsterdam UMC

Hands-On: Ablation *

HCC/Cholangio Tumor Board*

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard

Panelists: Zach Berman, MD, University of California San Diego; David Madoff, MD, Yale School of Medicine; Marina Baretti, MD, Johns Hopkins University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Jennifer Berumen. MD, University of California San Diego; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

Saturday 21 January 2023

Time (EST)

Session Title

Breakfast & Education Session - Optimal Preparation and Treatment Endpoints in cTACE *

• Sarah White, MD, MS, Medical College of Wisconsin
• William Rilling, MD, FSIR, Medical College of Wisconsin
• Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
• Nicholas Fidelman, MD, University of California San Francisco

Y90 Radioembolization for Primary & Metastatic Liver Cancer: One Size Does Not Fit All +

Moderators: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute

• Lung Shunt & Lung Dose Considerations, Marnix Lam, MD, PhD, University Medical Center Utrecht
• Multi-Compartment Dosimetry, Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute
• Dosimetry in Ablative Setting: Resin versus Glass, Beau Toskich, MD, Mayo Clinic
• Dosimetry in Non-Ablative Setting: Resin versus Glass, Nima Kokabi, MD, Emory University
• Post-Treatment Imaging: SPECT versus PET, Cheenu Kappadath, PhD, UT MD Anderson Cancer Center

Scientific Oral Abstracts *

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

• Bone Ablation with a Saline-Infused System, Amanda Smolock, MD, PhD, Medical College of Wisconsin
• Radiomics-based predictive models for new intrahepatic tumors following thermal ablation of colorectal liver metastasis, Iwan Paolucci, PhD, The University of Texas MD Anderson Cancer Center
• Is the minimal ablative margin measured on intraprocedural post-ablation CT better than first follow-up CT in predicting colorectal liver metastasis outcomes? Yuan-Mao Lin, MD, The University of Texas MD Anderson Cancer Center
• Circulating miR-21 as a prognostic biomarker for HCC treated with CT-guided high-dose rate brachytherapy, Matthias Stechele, MD, University Hospital, LMU Munich
• An injectable intratumoral immunoadjuvant depot overcomes check-point inhibitor resistant cancer at distant tumor sites through local immune system stimulation, Avik Som, MD, PhD, MGH
• MRI-guided trans-perineal focal cryoablation for primary prostate cancer, Aliza Mushtaq, MD, Mayo Clinic
• Immediate 3D Imaging Assessment is the Most Accurate Predictor of Local Tumor Progression after Microwave Ablation of CRC Liver Metastases, Mahdi Zirakchian Zadeh, MD, Memorial Sloan Kettering Cancer Center
• Development of Patient-Derived Hepatocellular Carcinoma (HCC) Tumoroids as a Platform for Preclinical Investigations of Liver-Directed Therapies, Christopher Malone, MD, Mallinckrodt Institute of Radiology at Washington University School of Medicine

Expo Hall Break - Discovery Theater Presentation by Varian, a Siemens Healthineers Company +

Image-Guided Cryoablation and Embolization in MSK: MSK Intervention with Cryotherapy and Embolization Using Integrated Angio-CT Solutions, Rahul Anil Sheth, MD

Liver Directed Therapy for Early Stage HCC *

Moderators: Kelvin Hong, MD, Johns Hopkins University; Laura Crocetti, MD, PhD, University of Pisa

• Surgical Approach, Andrew Cameron, MD, PhD, Johns Hopkins University
• Arterial Approach, Kelvin Hong, MD, Johns Hopkins University
• Ablation, Laura Crocetti, MD, PhD, University of Pisa
• Radiation Oncology, Amol Narang, MD, Johns Hopkins University

Lunch & Industry Symposium Presented by TriSalus - Seeking to Enable Immunotherapy for Liver and Pancreatic Tumors: Updates from PERIO Trials *

• Steven Katz, MD, FACS, TriSalus Life Sciences
• Alex Kim, MD, National Vascular Physicians
• Rahul Sheth, MD, MD Anderson Cancer Center

Lunch & Industry Symposium Presented by Sirtex - Resin Y-90 Dosimetry: From Theory to Practice *

• S. Cheenu Kappadath, PhD, MD Anderson Cancer Center
• Nima Kokabi, MD, FRCP, Emory University

Expo Hall Afternoon Hours - Discovery Theater Presentation by Varian, a Siemens Healthineers Company +

Is Access to Interventional Oncology Care in the US Equitable? Geographic Access to Interventional Oncology Care in the USA, Theresa M. Caridi, MD, FSIR

Women & Under-Represented Minorities in IO *

Moderators: Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

• Setting the Stage, Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Changing the Pipeline, Culture & Environment, Amy Deipolyi, MD, PhD, West Virginia University & Sherri Reed, Research Fellow, NIH
• Pigeonholing & Imposter Syndrome, Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill & Kirema Garcia-Reyes, MD, Mount Sinai Hospital
• He for She & Male Portraiture, Brad Wood, MD, NIH & Nicole Varble, NIH
• Panel Discussion

Planning Committee: Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill; Ji Buethe, MD, Johns Hopkins University; Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Sharon Kwan, MD, MS, Seattle Cancer Care Alliance

Expo Hall Networking & Oral Poster Presentations +

• Fusion-Guided Optical Molecular Imaging Liver Biopsy and Point-of-Care Tissue Assessment for Liver Neoplasms, Michael Kassin, MD, NIH
• Microwave Ablation of Stage IA Non-Small Cell Lung Cancers Detected at Low Dose CT Lung Cancer Screening in US Veterans: Midterm Results, Ericson John Torralba, Wright State University Boonshoft School of Medicine
• Rapid Diagnosis through IR Outpatient Clinic to Expedite Triage for Patients without a Cancer Diagnosis and Diffuse Imaging Findings Suggestive of Cancer, Suken Shah, MD, Memorial Sloan Kettering Cancer Center

Hands-On: Navigation & Guidance *

GU/Bone Tumor Board *

Moderators: Matthew Callstrom, MD, PhD, Mayo Clinic; Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens

Panelists: David Einstein, MD, Beth Israel Deaconess Medical Center; Steven Yevich, MD, MPH, MD Anderson Cancer Center; Damian Dupuy, MD, FACR, Cape Cod Hospital

Sunday 22 January 2023

Time (EST)

Session Title

HCC New Horizons *

• Introduction & Laudation, Julius Chapiro, MD, PhD, Yale University School of Medicine
• HCC New Horizons Keynote, David Madoff, MD, Yale School of Medicine

Scientific Oral Abstracts *

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

• Effect of injection rate on bead distribution and volume delivered during embolization in swine: Results from the AmCORE, Antonio Arrichiello, MD, National Institutes of Health
• Optimizing patient selection for treating colorectal liver metastases with glass radioembolization plus chemotherapy: The EPOCH study, Riad Salem, MD, MBA, Northwestern University
• Phase I Prospective Trial of TAS-102 (trifluridine and tipiracil) and Radioembolization for Chemo-refractory Colorectal Liver Metastases, Nicholas Fidelman, MD, University of California San Francisco
• Enhanced Delivery of a TLR9 Type C Agonist SD-101 to Liver Tumors in the Oncopig using Pressure Enabled Drug Delivery (PEDD) Versus a Standard Endhole Catheter, Thomas Hullinger, PhD, TriSalus Life Sciences
• Radiofrequency ablation induced tumor growth is suppressed by microRNA21 inhibition, Lukas Salvermoser, MD, University Hospital Munich
• Clinical study of CalliSpheres microspheres drug-eluting bead-transarterial chemoembolization combined with sintilimab in the treatment of unresectable HCC, Vineel Inampudi, Health Care Global Cancer Hospital
• MRI Radiomics Correlate with Clinical Outcomes of Peripheral Venous Malformations Following Percutaneous Sclerotherapy, Adham Khalil, MD, Johns Hopkins University
• Does Cancer Type Influence the Rate of Port Associated Infection? Alirezsa Zandifar, MD, Children's Hospital of Philadelphia

Lunch & Industry Symposium Presented by AstraZeneca - Newly Approved Treatment Options for Unresectable Hepatocellular Carcinoma *

• Bassam Estfan, MD, Cleveland Clinic

Lunch & Education Session - HCC Imaging and Chemoembolization 2023: New Techniques, New Science *

Moderator: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

• Latest Guidelines and Randomized Trials, Lambros Tselikas, MD, Gustave Roussy
• Biomarkers in Liver Cancer Therapy, Julius Chapiro, MD, PhD, Yale University School of Medicine

Expo Hall Afternoon Hours - Discovery Theater Presentation by Instylla +

Embrace (TM) HES for Tumor Embolization, Stephen Hunt, MD

Lung Cancer & Mets +

Moderators: Stephen Hunt, MTR, MD, PhD, University of Pennsylvania; Alda Tam, MD, MD Anderson Cancer Center

• Cutting Edge Clinical Trials in Lung Ablation, Alda Tam, MD, MD Anderson Cancer Center
• Combination Immunotherapy, Damian Dupuy, MD, FACR, Cape Cod Hospital
• Oligonodular Disease: Changing Landscape, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
• Thermal Therapy Considerations, Beau Toskich, MD, Mayo Clinic
• Hot Topics in Trial Design for Minimally Invasive Procedures, Florian Fintelmann, MD, Massachusetts General Hospital

Expo Hall Networking & Oral Poster Presentations +

• Clinical Feasibility of CT-based Dosimetry in Yttrium-90 Radioembolization Following the Administration of Radiopaque Glass Microspheres (Eye90), Robert Abraham, MD, Dalhousie University
• Targeting for Transcostal Histotripsy: Effect of Intervening Ribs on the Location of Cavitation, Katrina Falk, MS, University of Wisconsin-Madison
• Temporary Transvenous Pacer to Avoid Hypertensive Crisis during Percutaneous Ablation of Adrenal Metastasis: a single-center experience, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center

Hands-On: Treatment Planning & Simulation *

Liver Mets Tumor Board *

Moderators: Edward Kim, MD, Mount Sinai Health Systems; Nora Tabori, MD, MedStar

Panelists: Kelly Lafaro, Md, Johns Hopkins University; Mary Mulcahy, MD, Northwestern University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Nicholas Fidelman, MD, University of California San Francisco; Bruno Odisio, MD, FSIR, MD Anderson Cancer Center

Monday 23 January 2023

Time (EST)

Session Title

Technology +

Moderators: Joseph Amaral, MD, Histosonics; Damian Dupuy, MD, FACR, Cape Cod Hospital

• Pulsed Electrical Fields, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
• Histotripsy, Timothy Ziemlewicz, MD, UW Madison
• Robotic Endoscopy for Lung Cancer, Michael Pritchett, DO, MPH, Pinehurst Medical
• Bronchoscopic Lung Microwave Ablation, Michael Pritchett, DO, MPH, Pinehurst Medical
• Treatment Planning, Punit Prakash, PhD, Kansas State University

Case-Based Review +

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; R. Peter Lokken, MD, MPH, FSIR, University of California San Francisco

• Liver Embolization, Christos Georgiades, MD, PhD, Johns Hopkins University
• Liver Ablation, Bruno Odisio, MD, FSIR, MD Anderson Cancer Center
• Renal, Ryan Kohlbrenner, MD, University of California San Francisco
• Lung, Ji Buethe, MD, Johns Hopkins University
• MSK, A. Nick Kurup, MD, Mayo Clinic
• Complications: Miss, R. Peter Lokken, MD, MPH, FSIR, University of California San Francisco
• Complications: Save, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center

Closing Remarks +

Matthew Callstrom, MD, PhD, Mayo Clinic